Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin carboxyl-terminal hydrolase 4, pseudogene (ENSG00000267587) is annotated in genomic databases as a human pseudogene related by sequence to the ubiquitin carboxyl-terminal hydrolase family, particularly the functional gene USP4 (ubiquitin specific peptidase 4). Pseudogenes arise from gene duplication or retrotransposition events but acquire mutations that prevent them from encoding functional proteins. This particular locus does not produce a functional enzyme, nor has it been implicated as a drug target, signaling molecule, or biomarker. It is generally excluded from discussions of receptors, transporters, enzymes, or other conventional therapeutic targets because it does not encode a protein product. Given that Ubiquitin carboxyl-terminal hydrolase 4, pseudogene is a pseudogene and not a protein-coding gene, there is something "incorrect" about treating it as a molecular drug target or functional receptor. No drugs, mechanisms of action, safety considerations, or molecular functions are associated with this entry, and it should not be included in target-based drug discovery workflows. If you intended to reference the functional enzyme (USP4 or Ubiquitin carboxyl-terminal hydrolase 4), a correction is needed; otherwise, no further structured therapeutic information can be retrieved for this pseudogene entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 4, pseudogene.